Generation of B cell-deficient pigs by highly efficient CRISPR/Cas9-mediated gene targeting

Journal of Genetics and Genomics = Yi Chuan Xue Bao
Fengjiao ChenYifan Dai

Abstract

Generating B cell-deficient mutant is the first step to produce human antibody repertoires in large animal models. In this study, we applied the clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated (Cas) system to target the JH region of the pig IgM heavy chain gene which is crucial for B cell development and differentiation. Transfection of IgM-targeting Cas9 plasmid in primary porcine fetal fibroblasts (PFFs) enabled inducing gene knock out (KO) in up to 53.3% of colonies analyzed, a quarter of which harbored biallelic modification, which was much higher than that of the traditional homologous recombination (HR). With the aid of somatic cell nuclear transfer (SCNT) technology, three piglets with the biallelic IgM heavy chain gene mutation were produced. The piglets showed no antibody-producing B cells which indicated that the biallelic mutation of the IgM heavy chain gene effectively knocked out the function of the IgM and resulted in a B cell-deficient phenotype. Our study suggests that the CRISPR/Cas9 system combined with SCNT technology is an efficient genome-editing approach in pigs.

References

Mar 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·A JakobovitsG R Otten
Nov 14, 1996·The New England Journal of Medicine·L YelM E Conley
Aug 13, 2002·Cloning and Stem Cells·D Bart CarterRandall S Prather
Aug 13, 2002·Nature Biotechnology·Yoshimi KuroiwaJames M Robl
Sep 10, 2005·Nature Biotechnology·Nils Lonberg
Mar 23, 2006·Annual Review of Immunology·David JungFrederick W Alt
Mar 28, 2006·Nature Biotechnology·Liangxue LaiYifan Dai
Mar 29, 2008·Annual Review of Immunology·Troy D RandallJavier Rangel-Moreno
Sep 27, 2008·Science·Christopher S RogersMichael J Welsh
Jan 20, 2009·Nature Biotechnology·Yoshimi KuroiwaJames M Robl
Mar 27, 2010·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Bernhard AignerEckhard Wolf
Sep 28, 2010·Transgenic Research·J RamsoondarK Wells
Aug 9, 2011·Nature Biotechnology·Laurent TessonGregory J Cost
Jun 30, 2012·Science·Martin JinekEmmanuelle Charpentier
Jan 5, 2013·Science·Le CongFeng Zhang
Apr 3, 2013·Cell Research·Bin ShenXingxu Huang
Jun 26, 2013·Journal of Genetics and Genomics = Yi Chuan Xue Bao·Chuanxian WeiRenjie Jiao
Jun 25, 2013·Nature Biotechnology·Yanfang FuJeffry D Sander
Jul 23, 2013·Nature Biotechnology·Patrick D HsuFeng Zhang
Aug 10, 2013·Nature Biotechnology·Dali LiMingyao Liu
Sep 10, 2013·Proceedings of the National Academy of Sciences of the United States of America·Wenfang TanScott C Fahrenkrug
Dec 4, 2013·Cell Research·Yuanwu MaLianfeng Zhang
Feb 1, 2014·Journal of Genetics and Genomics = Yi Chuan Xue Bao·Andrew R Bassett, Ji-Long Liu
Aug 8, 2014·Biology of Reproduction·Kristin M WhitworthRandall S Prather
Oct 3, 2014·Cellular and Molecular Life Sciences : CMLS·Xiaoqing ZhouLiangxue Lai

❮ Previous
Next ❯

Citations

Sep 29, 2015·The Journal of Pathology·C Bruce A WhitelawBhanu P Telugu
May 31, 2016·International Journal of Molecular Sciences·Ki-Eun ParkBhanu P Telugu
Jan 20, 2017·Animal Biotechnology·Samantha N LottiMatthew B Wheeler
Oct 20, 2018·Proceedings of the National Academy of Sciences of the United States of America·Luca D BertzbachBenedikt B Kaufer
Dec 13, 2018·ILAR Journal·Jeffrey L PlattJorge A Piedrahita
Feb 13, 2019·Asian-Australasian Journal of Animal Sciences·Yueyun DingZongjun Yin
Jul 18, 2017·Mammalian Genome : Official Journal of the International Mammalian Genome Society·Bhanu P TeluguChi-Hun Park
Sep 21, 2018·Frontiers in Genetics·Huaqiang Yang, Zhenfang Wu
Oct 12, 2018·Disease Models & Mechanisms·Bin FangYifan Dai
Feb 6, 2016·Transgenic Research·Wenfang TanC Bruce A Whitelaw
Oct 3, 2020·Computational and Structural Biotechnology Journal·Yuanyuan Xu, Zhanjun Li
Feb 20, 2021·Frontiers in Genetics·Iuri Viotti PerisseIrina A Polejaeva
Feb 23, 2021·Journal of Genetics and Genomics = Yi Chuan Xue Bao·Xiaoxue LiYifan Dai
Mar 23, 2021·Frontiers in Genetics·Laura Daniela RatnerRafael Fernandez-Martin
May 1, 2021·Genes and Environment : the Official Journal of the Japanese Environmental Mutagen Society·Hussein SabitAfnan Al-Muhanaa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Fate Conversion By mRNA

mRNA-based technology is being studied as a potential technology that could be used to reprogram cell fate. This technique provides the potential to generate safe reprogrammed cells that can be used for clinical applications. Here is the latest research on cell fate conversion by mRNA.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

Antibody Repertoire Diversity

Antibody repertoire diversity and its role during natural infection is a prerequisite for molecular and structural elucidation of functionally protective immunity. Discover the latest insights into antibody diversity here.